| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/02/1999 | WO1999043706A1 Derivatives of glp-1 analogs |
| 09/02/1999 | WO1999043705A1 N-terminally truncated glp-1 derivatives |
| 09/02/1999 | WO1999043703A1 Method for immunochemically assaying anti-hm1.24 antibody |
| 09/02/1999 | WO1999043702A1 PROTEIN BINDING TO NE-dlg |
| 09/02/1999 | WO1999043701A2 Peptides for inhibition of apoptosis and pharmaceutical compositions containing them |
| 09/02/1999 | WO1999043696A1 Human potassium channel genes |
| 09/02/1999 | WO1999043695A1 Best's macular dystrophy gene |
| 09/02/1999 | WO1999043693A1 36 human secreted proteins |
| 09/02/1999 | WO1999043692A1 pyrH GENE AND PROTEIN OF STREPTOCOCCUS PNEUMONIAE |
| 09/02/1999 | WO1999043361A1 Glp-2 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates |
| 09/02/1999 | WO1999043360A1 Stable protection from dystrophic sarcolemmal degeneration and restoration of the sarcoglycan complex |
| 09/02/1999 | WO1999043346A1 Methods for diagnosing and treating autoimmune disease |
| 09/02/1999 | WO1999043341A1 Glp-1 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates |
| 09/02/1999 | WO1999043286A2 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 09/02/1999 | WO1999043208A1 The helios gene |
| 09/02/1999 | WO1999037795B1 PROMOTER AND REGULATOR SEQUENCES Ha ds10 G1: A GENE LEA OF SUNFLOWER EXPRESSED EXCLUSIVELY IN SEEDS FROM THE MATURATION PHASE |
| 09/02/1999 | WO1999034006A3 A method for the positive selection of cd4+ t-lymphocytes transduced with anti-hiv genes |
| 09/02/1999 | WO1999033867A3 Modified nucleic acid analogues |
| 09/02/1999 | WO1999033488A3 Adjuvanted vaccine formulation |
| 09/02/1999 | WO1999031274A3 Reagents and methods useful for detecting diseases of the pancreas |
| 09/02/1999 | WO1999031240A3 14-3-3σ ARRESTS THE CELL CYCLE |
| 09/02/1999 | WO1999029903A3 Cancer susceptibility mutations of brca1 |
| 09/02/1999 | WO1999028453A3 Transgenic non-human mammals with an oncogenic mutant of raf gene 1 |
| 09/02/1999 | WO1999028347A8 Method of designing agonists and antagonists to igf receptor |
| 09/02/1999 | WO1999027968A3 Oxidative method for attachment of glycoproteins or glycopeptides to surfaces of medical devices |
| 09/02/1999 | WO1999027109A3 EXTRACELLULAR MATRIX-BINDING PROTEINS FROM $i(STAPHYLOCOCCUS AUREUS) |
| 09/02/1999 | WO1999025732A3 Design of coiled-coil dimer derived antagonists of 4-helix bundle cytokine specific receptors |
| 09/02/1999 | WO1999024075A3 Affinity markers for human serum albumin |
| 09/02/1999 | WO1999023116A9 ASSAY EMPLOYING CadC FUSION PROTEINS |
| 09/02/1999 | WO1999023105A9 Vegi, an inhibitor of angiogenesis and tumor growth |
| 09/02/1999 | WO1999020766A3 NOVEL MODIFIED NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS |
| 09/02/1999 | WO1999019357A9 Cell regulatory genes, encoded products, and uses related thereto |
| 09/02/1999 | WO1999019348A8 Laminins and uses thereof |
| 09/02/1999 | WO1999015548B1 Isolated and recombinant antimicrobial peptides thrombocidin-1 (tc-1) and thrombocidin-2 (tc-2) or variants thereof |
| 09/02/1999 | WO1999014234A3 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/02/1999 | WO1999010498A3 Genes encoding enzymes for lignin biosynthesis and uses thereof |
| 09/02/1999 | WO1999002711A3 Fusion proteins with an immunoglobulin hinge region linker |
| 09/02/1999 | WO1998033917A9 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| 09/02/1999 | WO1998030693A9 Tumor necrosis factor receptor 5 |
| 09/02/1999 | WO1998027113A8 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5 |
| 09/02/1999 | CA2792479A1 Vaccines, immunotherapeutics and methods for using the same |
| 09/02/1999 | CA2322711A1 Human proteins having transmembrane domains and dnas encoding these proteins |
| 09/02/1999 | CA2322160A1 Vaccines, immunotherapeutics and methods for using the same |
| 09/02/1999 | CA2322070A1 Protein binding to ne-dlg |
| 09/02/1999 | CA2322066A1 A simplified system for generating recombinant adenoviruses |
| 09/02/1999 | CA2321993A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity |
| 09/02/1999 | CA2321974A1 Tumor associated antigen 791tgp72 |
| 09/02/1999 | CA2321970A1 36 human secreted proteins |
| 09/02/1999 | CA2321962A1 G protein-coupled receptor antagonists |
| 09/02/1999 | CA2321959A1 Methods for diagnosing and treating autoimmune disease |
| 09/02/1999 | CA2321950A1 Cultivar specificity gene from the rice pathogen magnaporthe grisea, and methods of use |
| 09/02/1999 | CA2321946A1 Methods and compositions using tumor specific soluble interleukin-2 receptor alpha molecules |
| 09/02/1999 | CA2321883A1 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 09/02/1999 | CA2321870A1 Cell cycle related proteins |
| 09/02/1999 | CA2321869A1 Human proteinase molecules |
| 09/02/1999 | CA2321747A1 Human smn-like protein |
| 09/02/1999 | CA2321746A1 Human protein kinase c inhibitor |
| 09/02/1999 | CA2321667A1 Human channel-related molecules |
| 09/02/1999 | CA2321194A1 Human potassium channel genes |
| 09/02/1999 | CA2321178A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1999 | CA2321142A1 Protease-activated receptor 4 and uses thereof |
| 09/02/1999 | CA2321129A1 Best's macular dystrophy gene |
| 09/02/1999 | CA2320403A1 Enhancing the circulating half-life of antibody-based fusion proteins |
| 09/02/1999 | CA2315549A1 Family of maize pr-1 genes and promoters |
| 09/02/1999 | CA2288219A1 Novel dna fragment directing gene expression predominant in flower organ |
| 09/02/1999 | CA2287226A1 Human c-maf compositions and methods of use thereof |
| 09/01/1999 | EP0939131A2 Aminopeptidases |
| 09/01/1999 | EP0939128A2 New HCV isolates |
| 09/01/1999 | EP0939127A2 Humanized immunoglobulins and their production and use |
| 09/01/1999 | EP0939126A1 Tumor suppressor gene Del-27 and the protein coded thereby, methods of production and use thereof |
| 09/01/1999 | EP0939124A2 MGBP1 sequences |
| 09/01/1999 | EP0939123A2 Estrogen receptor-related polypetide SBPERR4 |
| 09/01/1999 | EP0939122A1 Mouse TCF-3 and TCF-4 and tumorigenesis related to WNT/Wingless signalling |
| 09/01/1999 | EP0939121A2 TNF-binding proteins |
| 09/01/1999 | EP0939119A1 Transmembrane trapping methods |
| 09/01/1999 | EP0939085A1 A process for the purification of a motility-promoting protein from buffalo serum |
| 09/01/1999 | EP0939084A1 An estrogen binding proteinaceous substance, its possible role in estrogen action, and potential use. |
| 09/01/1999 | EP0939083A2 Ferro-succinylcasein complex, process for its preparation and pharmaceutical compositions containing it |
| 09/01/1999 | EP0939082A1 Protein polysaccharide 0041 |
| 09/01/1999 | EP0938881A1 Collagen-base auxiliary agent for ophthalmic surgery |
| 09/01/1999 | EP0938728A1 Magnetizable device |
| 09/01/1999 | EP0938679A2 Receptor binding assay, appropriate recombinant fusion receptor for said assay, vector for its production and reagent kit for implementing the receptor binding assay |
| 09/01/1999 | EP0938678A1 Method and kit for the diagnosis of troponin i |
| 09/01/1999 | EP0938585A1 Detection and quantitation of endotoxin by fluorescence polarization |
| 09/01/1999 | EP0938578A1 Genetic modification of primate hemopoietic repopulating stem cells |
| 09/01/1999 | EP0938577A2 Method for genetic control of seed maturation |
| 09/01/1999 | EP0938574A1 Method for inducing viral resistance into a plant |
| 09/01/1999 | EP0938572A1 Promoter from tobacco |
| 09/01/1999 | EP0938571A1 Method for the oligomerisation of peptides |
| 09/01/1999 | EP0938567A1 Applications for regulatory region of nos isoforms |
| 09/01/1999 | EP0938564A1 Disease resistance in vitis |
| 09/01/1999 | EP0938563A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods |
| 09/01/1999 | EP0938562A2 Pesticidal toxins and nucleotide sequences which encode these toxins |
| 09/01/1999 | EP0938561A1 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 09/01/1999 | EP0938560A1 GENOMIC NUCLEIC ACIDS, cDNA AND mRNA WHICH CODE FOR POLYPEPTIDES WITH IL-16 ACTIVITY, PROCESSES FOR THE PRODUCTION THEREOF AND THEIR USE |
| 09/01/1999 | EP0938559A2 HUMAN POLYHOMEOTIC 2 (hph2) ACTS AS A TUMOR SUPPRESSOR |
| 09/01/1999 | EP0938558A2 Gaba a receptor subunit epsilon-related protein |
| 09/01/1999 | EP0938557A2 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
| 09/01/1999 | EP0938556A1 Gamma-heregulin |
| 09/01/1999 | EP0938555A1 Constructs and complexes of cyclin e |